Detection of DNA hypermethylation in sera of patients with Crohn's disease

Molecular Medicine Reports

Volumn 9, Issue 2, 2014, Pages 725-729

  Bae, Jin Han ^a   Park, Jongha ^b   Yang, Kwang Mo ^a   Kim, Tae Oh ^b   Yi, Joo Mi ^a  

^a Dongnam Institute of Radiological and Medical Science   (South Korea)

^b Inje University College of Medicine   (South Korea)

Author keywords

Crohn's disease; DNA methylation; Hypermethylation

Indexed keywords

ADOLESCENT; ADULT; AGED; CHILD; CROHN DISEASE; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; TRANSCRIPTIONAL ELONGATION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84893848032     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1840     Document Type: Article

References (29)

1. Podolsky DK: Inflammatory bowel disease. N Engl J Med 347: 417-429, 2002.
2. Halfvarson J, Bodin L, Tysk C, Lindberg E and Järnerot G: Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 124: 1767-1773, 2003.
3. Thompson NP, Driscoll R, Pounder RE and Wakefield AJ: Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ 312: 95-96, 1996.
4. Tysk C, Lindberg E, Järnerot G and Flodérus-Myrhed B: Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 29: 990-996, 1988.
5. Yamazaki K, McGovern D, Ragoussis J, Paolucci M, Butler H, Jewell D, Cardon L, Takazoe M, Tanaka T, Ichimori T, Saito S, Sekine A, et al: Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet 14: 3499-3506, 2005.
6. Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A, Dassopoulos T, Bitton A, et al: A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314: 1461-1463, 2006.
7. Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, Huse K, Albrecht M, Mayr G, De La Vega FM, Briggs J, Günther S, Prescott NJ, et al: A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39: 207-211, 2007.
8. Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A, Green T, Kuballa P, Barmada MM, Datta LW, Shugart YY, Griffiths AM, et al: Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 39: 596-604, 2007.
9. Wellcome Trust Case Control Consortium: Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447: 661-678, 2007.
10. Parkes M, Barrett JC, Prescott NJ, Tremelling M, Anderson CA, Fisher SA, Roberts RG, Nimmo ER, Cummings FR, Soars D, Drummond H, Lees CW, et al: Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 39: 830-832, 2007.
11. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, Brant SR, Silverberg MS, Taylor KD, Barmada MM, Bitton A, Dassopoulos T, et al: Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 40: 955-962, 2008.
12. Petronis A and Petroniene R: Epigenetics of inflammatory bowel disease. Gut 47: 302-306, 2000.
13. Jones PA and Baylin SB: The epigenomics of cancer. Cell 128: 683-692, 2007
14. Robertson KD: DNA methylation and human disease. Nat Rev Genet 6: 597-610, 2005.
15. Maeda O, Ando T, Watanabe O, Ishiguro K, Ohmiya N, Niwa Y and Goto H: DNA hypermethylation in colorectal neoplasms and inflammatory bowel disease: a mini review. Inflammopharmacology 14: 204-206, 2006.
16. Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Maruyama N, Kamano T, Kamiya Y, Nakagawa Y, Fujita H, Nagasaka M, et al: Effect of MDR1 gene promoter methylation in patients with ulcerative colitis. Int J Mol Med 23: 521-527, 2009.
17. Yi JM, Dhir M, Guzzetta AA, Iacobuzio-Donahue CA, Heo K, Yang KM, Suzuki H, Toyota M, Kim HM and Ahuja N: DNA methylation biomarker candidates for early detection of colon cancer. Tumour Biol 33: 363-372, 2012.
18. Kim TO, Park J, Kang MJ, Lee SH, Jee SR, Ryu DY, Yang K and Yi JM: DNA hypermethylation of a selective gene panel as a risk marker for colon cancer in patients with ulcerative colitis. Int J Mol Med 31: 1255-1261, 2013.
19. Laird PW: The power and the promise of DNA methylation markers. Nat Rev Cancer 3: 253-266, 2003.
20. Widschwendter M and Menon U: Circulating methylated DNA: a new generation of tumor markers. Clin Cancer Res 12: 7205-7208, 2006.
21. Wallner M, Herbst A, Behrens A, Crispin A, Stieber P, Göke B, Lamerz R and Kolligs FT: Methylation of serum DNA is an independent prognostic marker in colorectal cancer. Clin Cancer Res 12: 7347-7352, 2006.
22. Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB and Herman JG: Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 59: 67-70, 1999.
23. deVos T, Tetzner R, Model F, Weiss G, Schuster M, Distler J, Steiger KV, Grützmann R, Pilarsky C, Habermann JK, Fleshner PR, Oubre BM, et al: Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem 55: 1337-1346, 2009.
24. Yang SK, Yun S, Kim JH, Park JY, Kim HY, Kim YH, Chang DK, Kim JS, Song IS, Park JB, Park ER, Kim KJ, et al: Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis 14: 542-549, 2008.
25. Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS and Zinsmeister AR: Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology 114: 1161-1168, 1998.
26. Lee YJ, Yang SK, Byeon JS, Myung SJ, Chang HS, Hong SS, Kim KJ, Lee GH, Jung HY, Hong WS, Kim JH, Min YI, et al: Analysis of colonoscopic findings in the differential diagnosis between intestinal tuberculosis and Crohn's disease. Endoscopy 38: 592-597, 2006.
27. Brentnall TA, Crispin DA, Rabinovitch PS, Haggitt RC, Rubin CE, Stevens AC and Burmer GC: Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 107: 369-378, 1994.
28. Schuebel KE, Chen W, Cope L, Glöckner SC, Suzuki H, Yi JM, Chan TA, Van Neste L, Van Criekinge W, van den Bosch S, van Engeland M, Ting AH, et al: Comparing the DNA hypermethylome with gene mutations in human colorectal cancer. PLoS Genet 3: 1709-1723, 2007.
29. Sánchez-Alvarez M, Goldstrohm AC, Garcia-Blanco MA and Suñé C: Human transcription elongation factor CA150 localizes to splicing factor-rich nuclear speckles and assembles transcription and splicing components into complexes through its amino and carboxyl regions. Mol Cell Biol 26: 4998-5014, 2006.